What Luo Shu can think of is that Musk has no reason not to think that he can get more inside information from the Amerikan government.
Although he is suspected to be Merlin, no one can touch him without evidence, not to mention Musk's close connection with the Amerikan military.
The CIA sent agents to monitor Zheng Li, and even directly invaded the research and development center of Kechuang Biotech in the Lion City. All the research materials of Kechuang Biotech on brain-computer connection were copied by the CIA.
This information also fell into the hands of Musk. After he showed it to Neuralink, Neuralink expressed confidence that it would produce results within a year.
Musk is well aware of the value represented by Merlin or the knowledge system behind Merlin. It is not difficult for him to obtain MagicCoin. What is difficult is how to maintain his current status in the future.
Musk believes that he needs to gain sufficient advantages in the current situation of information asymmetry.
His idea is just a fantasy, and Musk underestimated the difficulty of obtaining MagicCoin.
Not only planets with life can satisfy the conditions of Haber's algorithm. Only planets with the possibility of the birth of intelligent life can satisfy the conditions of Haber's algorithm.
The intelligent life here refers to having a soul. The wizard does not know the underlying logic of Haiber's algorithm and the soul. However, Haiber's discovery has theoretically proved that all planets where intelligent life may be born satisfy the algorithm.
For example, on the earth about 3.8 billion years ago, only LUCA existed. LUCA is obviously not an intelligent life, but it still conforms to the Heber algorithm, because intelligent life may be born on the earth in the future.
It is as if humans know the existence of dark matter and have theoretically proven the existence of dark matter, but cannot explain the underlying properties of dark matter.
In Zheng Li's vision, MagicCoin is the threshold, and only those who meet the conditions can gain the ability to cast spells.
There are many planets in the universe that meet the conditions, but it is very difficult for you to find the coordinates of such a planet.
The ability here is not unique to astronomers. Astronomers can only infer through their knowledge or observations that life may exist in certain galaxies.
First of all, the existence of life in these galaxies does not mean that there is intelligent life or that intelligent life can be born. Secondly, there is a big step to go from galaxies to specific planets.
Even if you can determine the planet, you cannot determine the specific coordinates of the planet through observation. You can only further narrow down the coordinates of the universe that comply with Heber's algorithm.
In the end, you still need to narrow down the range and then calculate the corresponding coordinate position through Heiber's algorithm and Heber's constant.
This is more of a test of your math skills, and astronomy only plays a supporting role.
Mathematics is the basis of all sciences, and a mage's spellcasting ability is highly correlated with his mathematical logic ability.
When you cannot understand the spell model and cannot mobilize your will to construct the spell model according to your own thinking, even a standard magic brain cannot bring out one ten thousandth of the mage's ability.
In addition, Magic Coin does not look like a blockchain in the traditional sense because it has the existence of a centralized individual like Merlin.
But in fact, many so-called blockchain technology applications are based on centralized institutions.
For example, if Facebook wants to issue Libra currency, Facebook is the centralized institution for Libra currency.
Even BTC has achieved decentralization on a technical level, but it has not achieved decentralization in a financial sense. It is still a virtual currency that is highly tied to the American financial system.
Including China’s desire to develop digital currencies, Hong Kong and Siam launched a project called Inthanon-LionRock in 2019.
It is said to be a cross-border payment experimental project that applies blockchain technology and digital currency technology. Its essence is to create a swift system to bypass Amerikan.
In the second year, the Central Bank of China stepped down personally and announced its participation in the multilateral central bank digital currency bridge (m-CBDC bridge) project. This project was established based on the second phase of Inthanon-LionRock.
The m-CBDC bridge project also claims to use blockchain technology to decentralize, but the Central Bank of China is the largest centralized institution, and you simply cannot bypass it.
Therefore, it does not mean that centralized nodes must not exist when applying blockchain technology.
Although Magic Coin has a centralized entity like Merlin, as long as Merlin does not personally interfere with the normal operation of Magic Coin, it can be regarded as a decentralized blockchain virtual currency.
It's just that Magic Coin is deeply tied to magic abilities and has unique value.
After the release of Magic Coin, all mainstream virtual currencies currently on the market have plummeted.
There is no way to stop the decline.
From an economic logic, the emergence of Magic Coin is like a water pump. As long as Merlin can come up with enough attractive knowledge to conduct transactions through Magic Coin.
Then the funds in the market will continuously flow into Magic Coin.
Whether it is a completely different technological system or a completely different virtual currency, the emergence of these two has had a drastic impact on the European and American economies and the virtual currency economy.
Stock markets around the world are falling, and the decline is even worse than the first wave of the epidemic worldwide.
Because global stock markets are in the doldrums.
The China Securities Regulatory Commission has the responsibility to boost the market, so they eagerly hope that Kechuang Biotech can be listed as soon as possible.
The listing process of Kechuang Biotechnology has reached the stage of review and inquiry by the Shanghai Stock Exchange Commission.
Shenhai Stock Exchange:
Your firm's "Review Inquiry Letter Regarding the Application Documents for the Initial Public Offering of Stocks and Listing on the Science and Technology Innovation Board of Suzhou Science and Technology Innovation Biotech Co., Ltd." (Shenzheng Keshen (Authorization) [2021] No. 201, hereinafter referred to as the "Review Inquiry" "Letter") has been received.
Due to the short establishment time of Kechuang Biotech, the shareholding structure is simple, with only five institutions holding shares except Zheng Li.
The product type is single, the financial report data is clear, and the China Securities Regulatory Commission urgently needs the listing of Science and Technology Biotechnology to boost morale.
Therefore, the content of the inquiry letter from Shenhai Stock Exchange is very simple. There are only two main questions:
"The application of each patent used for investment in the issuer's products and technologies, the amount of income generated, and whether it corresponds to the issuer's core technology; the rationality of the evaluation price of the patent used for investment and the fairness of the share price."
The patents here are mainly about whether the valuation of the patent for the industrial synthesis route of endorphins and the valuation of the brain-computer connection technology are reasonable.
"Based on Zheng Li's resume, explain whether the research and development process and technology sources used to invest in patented technologies involve Zheng Li's work results in his previous unit, and whether there are any disputes or potential disputes."
During the listing process of Ke Chuang Biotech, some self-media people indeed said that Jiangcheng University also had a share in the patent based on Zheng Li’s experience of publishing endorphin-related papers at Jiangcheng University.
It’s just that this statement did not cause waves. Shenhai Stock Exchange’s inquiry here also gave Kechuang Biotech an opportunity to publicly explain. As long as it is listed, no one will be able to use this as an argument in the future.
